ArticleThe Journal of pharmacology and experimental therapeutics2012

Activation of alternate prosurvival pathways accounts for acquired sunitinib resistance in U87MG glioma xenografts.

Qingyu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.